escitalopram has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumenthal, JA; Davidson, J; Hinderliter, A; Hoffman, BM; Jiang, W; Kraus, WE; Liao, L; Mabe, S; Sherwood, A; Smith, PJ; Watkins, LL | 1 |
| Blumenthal, JA; Davidson, J; Hinderliter, A; Hoffman, BM; Jiang, W; Kraus, WE; Liao, L; Sherwood, A; Smith, PJ; Watkins, LL | 1 |
2 trial(s) available for escitalopram and Coronary Disease
| Article | Year |
|---|---|
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial.
Topics: Anxiety; Citalopram; Coronary Disease; Escitalopram; Exercise; Follow-Up Studies; Humans; Selective Serotonin Reuptake Inhibitors | 2022 |
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial.
Topics: Aged; Anxiety Disorders; Comorbidity; Coronary Disease; Depression; Escitalopram; Exercise Therapy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors | 2021 |